IT1298492B1 - USE OF BETA3-ADRENERGIC AGONIST COMPOUNDS FOR THE PREPARATION OF DRUGS CAPABLE OF INDURING THE RELEASE OF THE "GLP-1" HORMONE - Google Patents
USE OF BETA3-ADRENERGIC AGONIST COMPOUNDS FOR THE PREPARATION OF DRUGS CAPABLE OF INDURING THE RELEASE OF THE "GLP-1" HORMONEInfo
- Publication number
- IT1298492B1 IT1298492B1 IT96TO000284A ITTO960284A IT1298492B1 IT 1298492 B1 IT1298492 B1 IT 1298492B1 IT 96TO000284 A IT96TO000284 A IT 96TO000284A IT TO960284 A ITTO960284 A IT TO960284A IT 1298492 B1 IT1298492 B1 IT 1298492B1
- Authority
- IT
- Italy
- Prior art keywords
- induring
- beta3
- glp
- hormone
- release
- Prior art date
Links
- 102100025101 GATA-type zinc finger protein 1 Human genes 0.000 title 1
- 101710198884 GATA-type zinc finger protein 1 Proteins 0.000 title 1
- DTHNMHAUYICORS-KTKZVXAJSA-N Glucagon-like peptide 1 Chemical compound C([C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC=1N=CNC=1)[C@@H](C)O)[C@@H](C)O)C(C)C)C1=CC=CC=C1 DTHNMHAUYICORS-KTKZVXAJSA-N 0.000 title 1
- 239000000048 adrenergic agonist Substances 0.000 title 1
- 150000001875 compounds Chemical class 0.000 title 1
- 239000003814 drug Substances 0.000 title 1
- 229940079593 drug Drugs 0.000 title 1
- 229940088597 hormone Drugs 0.000 title 1
- 239000005556 hormone Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Emergency Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Saccharide Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9504448A FR2732894B1 (en) | 1995-04-13 | 1995-04-13 | NEW USE OF BETA9-ADRENERGIC AGONIST COMPOUNDS |
FR9512694A FR2734482B1 (en) | 1995-04-13 | 1995-10-27 | NEW USE OF BETA3-ADRENERGIC AGONIST COMPOUNDS |
Publications (3)
Publication Number | Publication Date |
---|---|
ITTO960284A0 ITTO960284A0 (en) | 1996-04-12 |
ITTO960284A1 ITTO960284A1 (en) | 1997-10-12 |
IT1298492B1 true IT1298492B1 (en) | 2000-01-10 |
Family
ID=26231888
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IT96TO000284A IT1298492B1 (en) | 1995-04-13 | 1996-04-12 | USE OF BETA3-ADRENERGIC AGONIST COMPOUNDS FOR THE PREPARATION OF DRUGS CAPABLE OF INDURING THE RELEASE OF THE "GLP-1" HORMONE |
Country Status (3)
Country | Link |
---|---|
BE (1) | BE1009698A3 (en) |
FR (1) | FR2734482B1 (en) |
IT (1) | IT1298492B1 (en) |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5106867A (en) * | 1990-05-04 | 1992-04-21 | American Cyanamid Company | Method of increasing lean meat in edible animals |
US5061727A (en) * | 1990-05-04 | 1991-10-29 | American Cyanamid Company | Substituted 5-(2-((2-aryl-2-hydroxyethyl)amino)propyl)-1,3-benzodioxoles |
JPH06345731A (en) * | 1992-04-28 | 1994-12-20 | Dainippon Pharmaceut Co Ltd | 2- [2- (Indol-3-yl) ethylamino] -1-phenylethanol derivative |
-
1995
- 1995-10-27 FR FR9512694A patent/FR2734482B1/en not_active Expired - Fee Related
-
1996
- 1996-04-09 BE BE9600294A patent/BE1009698A3/en not_active IP Right Cessation
- 1996-04-12 IT IT96TO000284A patent/IT1298492B1/en active IP Right Grant
Also Published As
Publication number | Publication date |
---|---|
ITTO960284A1 (en) | 1997-10-12 |
FR2734482B1 (en) | 1997-08-14 |
BE1009698A3 (en) | 1997-07-01 |
FR2734482A1 (en) | 1996-11-29 |
ITTO960284A0 (en) | 1996-04-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IT1240360B (en) | USE OF AN ALPHA-HYDROXIVITAMIN D DERIVATIVE FOR THE PREPARATION OF A MEDICATION FOR THE TREATMENT OF HYPERPARATIROIDISM | |
ZA98691B (en) | Use of central cannabinoid receptor antagonists for the preparation of drugs | |
NO20073430L (en) | Use of an antibody against interleukin-6 receptor for the preparation of a pharmaceutical composition | |
BR9602705A (en) | Compound pharmaceutical composition process for the preparation of a compound and use | |
AU4396193A (en) | 3-benzylamino-2-phenyl-piperidine derivatives as substance p receptor antagonists | |
ATE219377T1 (en) | NEW GALENIC ORAL PHARMACEUTICAL FORMULATION | |
HUP0100266A3 (en) | 1-amino-alkylcyclohexane nmda receptor antagonists, pharmaceutical compositions containing the compounds and their preparations | |
NO20041007L (en) | Use of oxypurine nucleosides for the preparation of a pharmaceutical composition | |
ITMI912025A0 (en) | PROCEDURE FOR THE PREPARATION OF DEMETHYLEPIPODOPHYLLOTOXIN-BETA-DGLUCOSIDES | |
IT9019112A1 (en) | PHARMACEUTICAL COMPOSITIONS AND DOSAGE FORMS FOR THE ORAL ADMINISTRATION OF CALCITONIN | |
HUP0100171A3 (en) | Use of endothelin receptor antagonists for producing pharmaceutical preparations for combating obesity | |
MX14533A (en) | PROCEDURE FOR THE PREPARATION OF PHARMACEUTICAL COMPOUNDS | |
HUP9600517A3 (en) | New tricyclic derivatives, their preparation, their use for the preparation of optically active or valemic colchicine and thiocolchine and analogues and derivatives and intermediates | |
BR9812404A (en) | Combination of an endothelin antagonist, pharmaceutical preparation, process for preparing a pharmaceutical preparation, and use of a combination of a beta receptor blocker and an endothelin antagonist | |
IT1298492B1 (en) | USE OF BETA3-ADRENERGIC AGONIST COMPOUNDS FOR THE PREPARATION OF DRUGS CAPABLE OF INDURING THE RELEASE OF THE "GLP-1" HORMONE | |
ITMI951649A0 (en) | USE OF COMPOUNDS AGONISTS OR ANTAGONISTS OF PURINE P2 RECEPTORS FOR THE PREVENTION OF GLUTAMATE CYTOTOXICITY | |
AU2836495A (en) | Use of neurotensin antagonists for the preparation of diuretic drugs | |
ZA98484B (en) | Use of beta3-adrenergic receptor agonists for the preparation of healing drugs | |
IT1296495B1 (en) | USE OF BISPHOSPHONATES IN THE PREPARATION OF PHARMACEUTICAL FORMS FOR INTRAMUSCULAR ADMINISTRATION | |
IT1280428B1 (en) | PHARMACEUTICAL COMPOSITION FOR TOPICAL USE | |
IT9020943A0 (en) | PHARMACEUTICAL COMPOSITION FOR ORAL USE WITH MODIFIED RELEASE OF NON-STEROID ANTI-INFLAMMATORS | |
IT1215325B (en) | -H2 RECEPTOR ANTAGONIST COMPOUNDS AND PROCEDURE FOR THEIR PREPARATION. | |
ITMI931371A1 (en) | PROCEDURE FOR THE PREPARATION OF ERDOSTEIN | |
IT1275457B (en) | USE OF ENDORPHINE SEQUENCES FOR THE PREPARATION OF AN IMMUNOSUPPRESSOR DRUG WITHOUT OPPIACEA ACTIVITY | |
ITMI931049A1 (en) | MUCOADHESIVE PHARMACEUTICAL COMPOSITION WITH CONTROLLED RELEASE FOR THE ORAL ADMINISTRATION OF FUROSEMIDE |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
0001 | Granted |